Nelson, R P <br/><br/>
Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.  [electronic resource] 

 -  Bone marrow transplantation  Dec 2002 
 - 805-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1703740  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--immunology<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Cyclophosphamide<br/>Cytokines--therapeutic use<br/>Graft Survival<br/>Graft vs Host Disease--etiology<br/>Graft vs Tumor Effect<br/>Humans<br/>Immunotherapy, Adoptive<br/>Kidney Neoplasms--immunology<br/>Melphalan<br/>Multicenter Studies as Topic<br/>Nephrectomy<br/>Peripheral Blood Stem Cell Transplantation--adverse effects<br/>Recombinant Proteins--therapeutic use<br/>Survival Analysis<br/>Thiotepa<br/>Transplantation Chimera<br/>Transplantation Conditioning--methods<br/>Treatment Outcome<br/>Vidarabine--analogs & derivatives